医保定点机构 这些骗保行为将受罚

Core Viewpoint - The implementation details of the "Regulations on the Supervision and Management of Medical Security Fund Usage" will take effect on April 1, 2026, emphasizing stricter oversight of medical services and pharmaceutical expenses [1][2] Group 1: Regulatory Measures - The regulations require medical security administrative departments at all levels to enhance supervision of medical service behaviors and pharmaceutical costs, conducting inspections and legally addressing violations [1] - Specific penalties are outlined for various violations, such as fines ranging from 10,000 to 50,000 yuan for designated medical institutions that fail to use drug traceability codes as required [1] Group 2: Fraud Prevention - The regulations define ten types of violations, including excessive diagnosis and treatment, splitting prescriptions, and fraudulent billing practices, with clear definitions for each [1] - For fraudulent insurance claims, specific scenarios are listed, with severe penalties including fines of two to five times the amount fraudulently obtained and suspension of related medical services for six months to one year [1] - Medical security agencies can suspend settlements and payments to designated medical institutions suspected of fraud that refuse to cooperate with investigations [2]